Vybion: Patent Issues to Vybion for Novel Huntingtons and Alzheimers Disease Gene Therapy

Vybion announces the issue by the USPTO of Patent No. 9932394 entitled Single Chain Intrabodies that Alter Huntingtin Mutant Degradation. Issued claims cover composition of matter as well as both the Huntingtin and Tau protein targe...